Table 2.
eGFR formula development population (n = 55) | eGFR formula testing population (n = 25) | P value | |
---|---|---|---|
Age (yrs) | 12.8 ± 3.2 | 12.4 ±3.7 | .626 |
Sex | FN n = 27 MN n = 28 |
FN n = 13 MN n = 12 |
.830 |
Breed | DSH/DLH n = 40 Pedigree n = 15 |
DSH/DLH n = 17 Pedigree n = 8 |
.885 |
GFR (mL/min/kg) | 1.54 ± 0.57 | 1.87 ± 0.56 | .016 |
Serum creatinine concentration (μmol/L) | 154.15 ± 50.55 | 155.89 ± 52.86 | .941 |
Reciprocal of serum creatinine concentration (μmol/L) | 0.007 ± 0.002 | 0.007 ± 0.002 | .925 |
Serum urea concentration (mmol/L) | 12.02 ± 3.80 | 12.28 ± 4.00 | .895 |
USG | 1.046 ± 0.022 | 1.039 ± 0.021 | .200 |
Body weight (kg) | 4.42 ± 1.14 | 4.20 ± 1.31 | .463 |
Body condition score (1‐9) | 6 ± 1 | 5 ± 1 | .228 |
Fat‐free mass (kg) | 3.07 ± 0.62 | Not measured | n/a |
Predicted fat‐free mass (kg) | 3.05 ± 0.59 | 3.02 ± 0.71 | .909 |
Predicted muscle mass (kg) | 2.02 ± 0.51 | 1.99 ± 0.66 | .824 |
Left forelimb circumference (cm) | 8.29 ± 0.94 | 7.91 ± 0.96 | .103 |
Right forelimb circumference (cm) | 8.05 ± 0.91 | 8.12 ± 0.89 | .621 |
Left hindlimb circumference (cm) | 9.22 ± 1.01 | 8.93 ± 1.12 | .242 |
Right hindlimb circumference (cm) | 9.03 ± 1.08 | 8.82 ± 0.95 | .416 |
Left proximal hindlimb circumference (cm) | 24.60 ± 4.04 | 23.30 ± 2.80 | .152 |
Right proximal hindlimb circumference (cm) | 25.95 ± 4.30 | 23.72 ± 3.36 | .026 |
Thoracic circumference (cm) | 40.34 ± 4.93 | 39.28 ± 4.84 | .378 |
Pelvic circumference (cm) | 41.00 ± 7.04 | 38.48 ± 6.73 | .141 |
Body length (cm) | 53.30 ± 5.14 | 53.28 ± 2.71 | .983 |
Forelimb height (cm) | 26.70 ± 3.13 | 36.93 ± 3.04 | .764 |
Hindlimb height (cm) | 29.61 ± 3.29 | 28.14 ± 3.04 | .062 |